Mkango Resources' HyProMag Chosen for Key Project by Minerals Security Partnership
Mkango Resources' recycling company, HyProMag, chosen by Minerals Security Partnership to support responsible critical mineral supply chains for net z...
News
HCL Technologies Q2 Report
HCL Technologies is set to release its Q2 results, with forecasted increases in net profit and revenue. Investors are interested in guidance updates,...
Charles M. Hall
Long-Term Bonds Still Appealing
Losses on long-term bonds have affected Wells Fargo Investment Institute, but they remain optimistic about long-term fixed income and favor duration.
Charles M. Hall
Intrusion Secures $5 Million Contract with Telecommunications Provider
Intrusion has secured a $5 million contract with a telecommunications provider for Intrusion Shield support, leading to a significant boost in the com...
Charles M. Hall
Wholesale Inventories in the U.S. Decline for the Sixth Consecutive Month
Wholesale inventories in the U.S. declined for the sixth consecutive month, reflecting a concerning trend in the market. However, motor vehicle invent...
Charles M. Hall
Bitcoin Price Stagnates as Market Watches Key Levels
The price of Bitcoin has shown little change in the past 24 hours, hovering around $27,650. Analysts believe that Bitcoin's inability to break key res...
Charles M. Hall
Electing a New Speaker: House Republicans Return to Washington
House Republicans return to elect a new speaker amid the ongoing conflict in Israel and looming government shutdown. Potential candidates and their im...
Charles M. Hall
Israeli Cybersecurity Stocks Face Setback Amidst Escalation of Conflict
Several U.S.-listed security-software stocks in Israel decline as conflict with Hamas continues. Analysis of market impact and companies' exposure.
Charles M. Hall
Potential Benefits for Stocks Amidst Israel-Gaza Conflict
Despite the tragedy of the Israel-Gaza conflict, declining interest rates may provide support for equity valuation.
Charles M. Hall
Bristol Myers Squibb to Acquire Mirati Therapeutics for $5.8 Billion
Bristol Myers Squibb plans to acquire Mirati Therapeutics for $5.8 billion, a strategic move to combat competition and create shareholder value in the...
Charles M. Hall
Popular
All Rights Reserved © 2023